New drugs for the treatment of hypertension

Giuseppe Mancia, Maria Luisa Stella, Guido Grassi

Research output: Contribution to journalArticle

11 Citations (Scopus)

Abstract

Despite the many outstanding favorable results achieved in the treatment of hypertension, several unmet goals of antihypertensive therapy remain, such as better blood pressure control, greater protection against the organ damage associated with hypertension, better tolerability, and ultimately a more effective prevention of cardiovascular disease. These unmet goals are the reasons why new antihypertensive drugs are synthesized and tested in the clinical practice. This paper briefly mentions the goals of new antihypertensive agents and examines the main pharmacological and clinical features of new classes of antihypertensive drugs, such as angiotensin II receptor blockers, central agents, vasopeptidase inhibitors, and endothelin antagonists. The results of experimental and clinical studies with these new drugs are reviewed, emphasizing some advantages and potential disadvantages of these drugs compared with traditional antihypertensive drugs.

Original languageEnglish
Pages (from-to)375-380
Number of pages6
JournalCurrent Opinion in Cardiology
Volume14
Issue number5
DOIs
Publication statusPublished - 1999

Fingerprint

Antihypertensive Agents
Hypertension
Pharmaceutical Preparations
Angiotensin Receptor Antagonists
Cardiovascular Diseases
Pharmacology
Blood Pressure
Therapeutics

ASJC Scopus subject areas

  • Cardiology and Cardiovascular Medicine

Cite this

New drugs for the treatment of hypertension. / Mancia, Giuseppe; Stella, Maria Luisa; Grassi, Guido.

In: Current Opinion in Cardiology, Vol. 14, No. 5, 1999, p. 375-380.

Research output: Contribution to journalArticle

Mancia, Giuseppe ; Stella, Maria Luisa ; Grassi, Guido. / New drugs for the treatment of hypertension. In: Current Opinion in Cardiology. 1999 ; Vol. 14, No. 5. pp. 375-380.
@article{9263a45d96b24471a2a7dbe959d007de,
title = "New drugs for the treatment of hypertension",
abstract = "Despite the many outstanding favorable results achieved in the treatment of hypertension, several unmet goals of antihypertensive therapy remain, such as better blood pressure control, greater protection against the organ damage associated with hypertension, better tolerability, and ultimately a more effective prevention of cardiovascular disease. These unmet goals are the reasons why new antihypertensive drugs are synthesized and tested in the clinical practice. This paper briefly mentions the goals of new antihypertensive agents and examines the main pharmacological and clinical features of new classes of antihypertensive drugs, such as angiotensin II receptor blockers, central agents, vasopeptidase inhibitors, and endothelin antagonists. The results of experimental and clinical studies with these new drugs are reviewed, emphasizing some advantages and potential disadvantages of these drugs compared with traditional antihypertensive drugs.",
author = "Giuseppe Mancia and Stella, {Maria Luisa} and Guido Grassi",
year = "1999",
doi = "10.1097/00001573-199909000-00004",
language = "English",
volume = "14",
pages = "375--380",
journal = "Current Opinion in Cardiology",
issn = "0268-4705",
publisher = "Lippincott Williams and Wilkins",
number = "5",

}

TY - JOUR

T1 - New drugs for the treatment of hypertension

AU - Mancia, Giuseppe

AU - Stella, Maria Luisa

AU - Grassi, Guido

PY - 1999

Y1 - 1999

N2 - Despite the many outstanding favorable results achieved in the treatment of hypertension, several unmet goals of antihypertensive therapy remain, such as better blood pressure control, greater protection against the organ damage associated with hypertension, better tolerability, and ultimately a more effective prevention of cardiovascular disease. These unmet goals are the reasons why new antihypertensive drugs are synthesized and tested in the clinical practice. This paper briefly mentions the goals of new antihypertensive agents and examines the main pharmacological and clinical features of new classes of antihypertensive drugs, such as angiotensin II receptor blockers, central agents, vasopeptidase inhibitors, and endothelin antagonists. The results of experimental and clinical studies with these new drugs are reviewed, emphasizing some advantages and potential disadvantages of these drugs compared with traditional antihypertensive drugs.

AB - Despite the many outstanding favorable results achieved in the treatment of hypertension, several unmet goals of antihypertensive therapy remain, such as better blood pressure control, greater protection against the organ damage associated with hypertension, better tolerability, and ultimately a more effective prevention of cardiovascular disease. These unmet goals are the reasons why new antihypertensive drugs are synthesized and tested in the clinical practice. This paper briefly mentions the goals of new antihypertensive agents and examines the main pharmacological and clinical features of new classes of antihypertensive drugs, such as angiotensin II receptor blockers, central agents, vasopeptidase inhibitors, and endothelin antagonists. The results of experimental and clinical studies with these new drugs are reviewed, emphasizing some advantages and potential disadvantages of these drugs compared with traditional antihypertensive drugs.

UR - http://www.scopus.com/inward/record.url?scp=0032822422&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=0032822422&partnerID=8YFLogxK

U2 - 10.1097/00001573-199909000-00004

DO - 10.1097/00001573-199909000-00004

M3 - Article

VL - 14

SP - 375

EP - 380

JO - Current Opinion in Cardiology

JF - Current Opinion in Cardiology

SN - 0268-4705

IS - 5

ER -